Literature DB >> 17708251

Locally advanced intrahepatic cholangiocarcinoma successfully resected after transcatheter arterial chemoembolization with degradable starch microspheres: report of a case.

Yongyou Wu1, Akio Saiura, Junji Yamamoto, Rintaro Koga, Shingo Asahara, Akira Kamei, Koichi Takano, Takaaki Ikari, Makoto Seki, Toshiharu Yamaguchi, Tetsuichiro Muto.   

Abstract

We describe a case of initially unresectable locally advanced intrahepatic cholangiocarcinoma that showed remarkable regression after transcatheter arterial chemoembolization with degradable starch microspheres, allowing for subsequent successful curative resection. A 75-year-old female was referred to our hospital with a large hepatic mass. Computerized tomography examination showed a huge mass in the right liver extended partially to the left liver. Intrahepatic cholangiocarcinoma was strongly suspected, but surgical resection was abandoned due to the local spread in the liver. Three courses of transcatheter arterial chemoembolization with degradable starch microspheres were performed. The anticancer agents, mitomycin C and epirubicin, combined with degradable starch microspheres were injected from the catheter for chemoembolization. After three courses of transcatheter arterial chemoembolization, the tumor size decreased from 10cm to 5.5cm in diameter. Then right trisegmentectomy together with extra-hepatic bile duct excision was performed. At 25 months after the first therapy and 21 months after operation, the patient remains healthy without recurrence. Transcatheter arterial chemotherapy with degradable starch microspheres may be a treatment of choice with locally advanced intrahepatic cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708251

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma.

Authors:  Peng Yuan; Jinhua Song; Fei Wang; Guangyu Zhu; Baoan Chen
Journal:  Invest New Drugs       Date:  2022-07-06       Impact factor: 3.651

Review 2.  Current status of intrahepatic cholangiocarcinoma.

Authors:  Jian Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

3.  Effects of I125 seed stent implantation combined with arterial infusion chemoembolization on tumor markers, p53 expression, and prognosis in patients with cholangiocarcinoma.

Authors:  Zhe Xu; Minglin Xu; Meng Li; Zhe Cui; Haisheng Bai; Heqing Shang; Jianyu Zhao; Lei Wu; Fan Zhang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

4.  Case: Authentic multimodal therapy and liver resection for an initially unresectable intrahepatic cholangiocarcinoma.

Authors:  Koichiro Sakata; Daiki Kijima; Taizo Yamaguchi; Takashi Furuhashi; Toshihiko Abe; Haruki Iwamoto; Katsuhiko Morita
Journal:  Int J Surg Case Rep       Date:  2018-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.